Cargando…
Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IR(A) axis in malignant mesothelioma
Malignant mesothelioma is a deadly disease with limited therapeutic options. EphB4 is an oncogenic tyrosine kinase receptor expressed in malignant mesothelioma as well as in a variety of cancers. It is involved in tumor microenvironment mediating angiogenesis and invasive cellular effects via both E...
Autores principales: | Scalia, Pierluigi, Pandini, Giuseppe, Carnevale, Vincenzo, Giordano, Antonio, Williams, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075896/ https://www.ncbi.nlm.nih.gov/pubmed/31270394 http://dx.doi.org/10.1038/s41388-019-0854-y |
Ejemplares similares
-
Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IR(A) Signal in Malignant Mesothelioma
por: Scalia, Pierluigi, et al.
Publicado: (2023) -
EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013) -
Core Element Cloning, Cis-Element Mapping and Serum Regulation of the Human EphB4 Promoter: A Novel TATA-Less Inr/MTE/DPE-Like Regulated Gene
por: Scalia, Pierluigi, et al.
Publicado: (2019) -
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
Paradoxes of the EphB1 receptor in malignant brain tumors
por: Wei, Wenqiang, et al.
Publicado: (2017)